Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients

BACKGROUND: Radio-chemotherapy with CDDP is the standard for H&N squamous cell cancer. CDDP 100 mg/m(2)/q3 is the standard; alternative schedules are used to reduce toxicity, mostly 40 mg/m(2)/q1. METHODS: Patients were treated from 1/2010 to 1/2017 in two Radiation Oncology Centres. Propensity...

Descripción completa

Detalles Bibliográficos
Autores principales: Buglione, Michela, Alterio, Daniela, Maddalo, Marta, Greco, Diana, Gerardi, Marianna Alessandra, Tomasini, Davide, Pegurri, Ludovica, Augugliaro, Matteo, Marvaso, Giulia, Turturici, Irene, Guerini, Andrea, Ansarin, Mohssen, Spiazzi, Luigi, Costa, Loredana, Cossu Rocca, Maria, Magrini, Stefano Maria, Jereczek-Fossa, Barbara Alicja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686550/
https://www.ncbi.nlm.nih.gov/pubmed/34930353
http://dx.doi.org/10.1186/s13014-021-01966-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686550/
https://www.ncbi.nlm.nih.gov/pubmed/34930353
http://dx.doi.org/10.1186/s13014-021-01966-4

Ejemplares similares